Asia and Global Semiconductor and Tech Research

Andrew Lu

Equity Bottom-Up

Taigen Biopharmaceuticals / Equity Bottom-Up

<h2>Summary</h2><ul>
<li>
<strong>What's new? </strong>Taigen and HEC Pharm announced a new joint venture.  HEC Pharm agrees Taigen to use its developed new drug Furaprevir (TG-2349) at RMB$335mn or NT$1.56bn investment value to take 49% of the new company.</li>
<li>
<strong>What is Furaprevir? </strong>On August 18, 2016, Taigen received a clinical trial authorization for Class 1.1 new drug from China Food and Drug Administration (CFDA) for Furaprevir. Furaprevir is an investigational HCV NS3 protease inhibitor discovered and developed by TaiGen for the…</li>
</ul>

Summary

What's new? Taigen and HEC Pharm announced a new joint venture.  HEC Pharm agrees Taigen to use its developed new drug Furaprevir (TG-2349) at RMB$335mn or NT$1.56bn investment value to take 49% of the new company.

What is Furaprevir? On August 18, 2016, Taigen received a clinical trial authorization for Class 1.1 new drug from China Food and Drug Administration (CFDA) for Furaprevir. Furaprevir is an investigational HCV NS3 protease inhibitor discovered and developed by TaiGen for the…


TaiGen Sold Its Furaprevir for 25x of Market Capital

Taiwan

Mycenax Biotech Inc. develops and manufactures biopharmaceutical products derived from mammalian cell culture and microbial fermentation.

Adimmune Corp. is a human vaccine manufacturer. The company focuses on vaccines, diagnostics, and biological products. Adimmune manufactures vaccines such as the JEV, Tuberculin PPD, Tetanus toxoid, and influenza.

PharmaEngine, Inc. operates as a biopharmaceutical company. The Company focuses on the development of new drugs for the treatment of cancer and Asian prevalent diseases.

OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.

Medigen Biotechnology Corp. researches and develops anti-cancer biopharmaceuticals.

SunMax Biotechnology Co Ltd. is a medical device company dedicated to the development, manufacturing and commercialization of bio-surgical products. The Company specializes in the production of medical grade porcine collagen that is used in medical applications and biochemistry research.

Medigen Vaccine Biologics Corporation operates as a vaccination company. The Company develops flu vaccine, enterovirus vaccine, and other related products. Medigen Vaccine Biologics markets its products throughout worldwide.

Golden Biotechnology Corporation specializes in the development of bio-medicines based on its research in the fields of modern biotechnology and molecular medicine.

TCM Biotech International Corporation conducts drug research. The Company specializes in innovative research and development of botanic drugs, health food and functional ingredients. TCM Biotech International serves customers throughout Taiwan and internationally.

GlycoNex Inc. owns complete R&D facilities including SPF animal room, cell culture room and glyco analysis equipment. The Company's main business is the development and authorization of monoclonal anti bodies and other services on carbohydrate antigen and protein drugs.

Enanta Pharmaceuticals, Inc. manufactures pharmaceutical products. The Company develops, produces, and markets antibacterial drugs for hepatitis C virus, respiratory tract infections, intravenous, and oral treatments for hospitals and communities. Enanta Pharmaceuticals offers its products throughout the United States.

MacroGenics, Inc. develops novel biologics. The Company specializes in treatments for autoimmune disorders, cancer, and infectious diseases. MacroGenics serves the healthcare industry in the United States.

Quantum Hi-Tech China Biological Co Ltd researches, develops, produces and sells fructooligosaccharides (FOS) products. The Company's main products are fructooligosaccharides, galacto-oligosaccharide and complex oligosaccharides.

Quantum Hi Tech (China) Biologicl (300149 CH)

XOMA Corporation is a biotechnology royalty aggregator playing a unique role in helping biotech companies to improve human health. The Company focuses on acquiring economic rights to future milestone and royalty payments associated with partnered pre-commercial clinical candidates in return the seller receives non-dilutive and non-recourse funding to advance their internal drug candidates.

Beijing Leadman Biochemistry Company Limited develops, manufactures and sells in vitro diagnostic products and biochemical raw materials. The Company's main products include in vitro diagnostic reagents, and biochemical raw materials.

Hester Biosciences Limited manufactures Poultry Vaccines.  The company produces live and inactive veterinary vaccines.

Grandhope Biotech Company Limited develops, manufactures and markets regenerative medical materials and regenerative implantable medical devices.

Opthea Limited is a biologics drug developer for ophthalmic diseases. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.

Jiangsu Sihuan Bioengineering Co., Ltd. operates in the  pharmaceutical industry.  The Company's products include injections, tablets, bioengineering products, and other related products.

Jiangsu Sihuan Bioengineering Co., (000518 CH)

TaiGen Biopharmaceuticals Holdings Limited is a research-based pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer research and diabetes-related complications.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Taigen Biopharmaceuticals (4157 TT)

TaiGen Sold Its Furaprevir for 25x of Market Capital

Summary What's new? Taigen and HEC Pharm announced a new joint venture. HEC Pharm agrees Taigen to use its developed new drug Furaprevir...

Andrew Lu

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)